Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray A Raskind

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Experimental Neurology|May 26, 2016
Noradrenergic dysregulation in the pathophysiology of PTSDRebecca C Hendrickson, Murray A Raskind
The American Journal of Psychiatry|July 2, 2014
Violence in war and violence back homeMurray A Raskind, Creed McCaslin, Matthew Jakupcak
Alcohol (Fayetteville, N.Y.)|August 15, 2006
Chronic daily ethanol and withdrawal: 6. Effects on rat sympathoadrenal activity during "abstinence"Dennis D Rasmussen, Charles W Wilkinson, Murray A Raskind
Journal of Traumatic Stress|October 9, 2010
Prazosin treatment of trauma nightmares and sleep disturbance in soldiers deployed in IraqJess Calohan, Kris Peterson, Elaine R Peskind, et al.
Neurobiology of Aging|October 7, 2004
Increased galanin receptor occupancy in Alzheimer's diseasePamela J McMillan, Elaine Peskind, Murray A Raskind, et al.
Stress (Amsterdam, Netherlands)|July 28, 2011
The neurobiology of the stress-resistant brainMonika Fleshner, Steven F Maier, David M Lyons, et al.
The Journal of Clinical Psychiatry|January 2, 2007
Beneficial effects of prazosin for visual hallucinations associated with chronic cocaine abuseAndre M Tapp, Annette Kennedy, Elaine R Peskind, et al.
Frontiers in Pharmacology|November 7, 2012
Sequential Loss of LC Noradrenergic and Dopaminergic Neurons Results in a Correlation of Dopaminergic Neuronal Number to Striatal Dopamine ConcentrationPatricia Szot, Allyn Franklin, Carl Sikkema, et al.
Frontiers in Digital Health|October 29, 2021
Optimizing Aggregated N-Of-1 Trial Designs for Predictive Biomarker Validation: Statistical Methods and Theoretical FindingsRebecca C Hendrickson, Ronald G Thomas, Nicholas J Schork, et al.
Alcoholism, Clinical and Experimental Research|November 27, 2008
The alpha1-adrenergic receptor antagonist, prazosin, reduces alcohol drinking in alcohol-preferring (P) ratsDennis D Rasmussen, Laura L Alexander, Murray A Raskind, et al.
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Experimental Neurology|May 26, 2016
Noradrenergic dysregulation in the pathophysiology of PTSDRebecca C Hendrickson, Murray A Raskind
The American Journal of Psychiatry|July 2, 2014
Violence in war and violence back homeMurray A Raskind, Creed McCaslin, Matthew Jakupcak
Alcohol (Fayetteville, N.Y.)|August 15, 2006
Chronic daily ethanol and withdrawal: 6. Effects on rat sympathoadrenal activity during "abstinence"Dennis D Rasmussen, Charles W Wilkinson, Murray A Raskind
Journal of Traumatic Stress|October 9, 2010
Prazosin treatment of trauma nightmares and sleep disturbance in soldiers deployed in IraqJess Calohan, Kris Peterson, Elaine R Peskind, et al.
Neurobiology of Aging|October 7, 2004
Increased galanin receptor occupancy in Alzheimer's diseasePamela J McMillan, Elaine Peskind, Murray A Raskind, et al.
Stress (Amsterdam, Netherlands)|July 28, 2011
The neurobiology of the stress-resistant brainMonika Fleshner, Steven F Maier, David M Lyons, et al.
The Journal of Clinical Psychiatry|January 2, 2007
Beneficial effects of prazosin for visual hallucinations associated with chronic cocaine abuseAndre M Tapp, Annette Kennedy, Elaine R Peskind, et al.
Frontiers in Pharmacology|November 7, 2012
Sequential Loss of LC Noradrenergic and Dopaminergic Neurons Results in a Correlation of Dopaminergic Neuronal Number to Striatal Dopamine ConcentrationPatricia Szot, Allyn Franklin, Carl Sikkema, et al.
Frontiers in Digital Health|October 29, 2021
Optimizing Aggregated N-Of-1 Trial Designs for Predictive Biomarker Validation: Statistical Methods and Theoretical FindingsRebecca C Hendrickson, Ronald G Thomas, Nicholas J Schork, et al.
Alcoholism, Clinical and Experimental Research|November 27, 2008
The alpha1-adrenergic receptor antagonist, prazosin, reduces alcohol drinking in alcohol-preferring (P) ratsDennis D Rasmussen, Laura L Alexander, Murray A Raskind, et al.
Pageof 9